Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-06-01T14:24:28.498Z Has data issue: false hasContentIssue false

Depression and HPA-axis dysregulation: A large cohort study

Published online by Cambridge University Press:  16 April 2020

F. Zitman
Affiliation:
Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands
S. Vreeburg
Affiliation:
Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands
B. Kruijtzer
Affiliation:
C.K.C.L., Leiden University Medical Center, Leiden, The Netherlands
H. van Pelt
Affiliation:
C.K.C.L., Leiden University Medical Center, Leiden, The Netherlands
R. van Dyck
Affiliation:
Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands
R. de Rijk
Affiliation:
L.A.C.D.R., Leiden, The Netherlands
W. Hoogendijk
Affiliation:
Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands
B. Penninx
Affiliation:
Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

There is a central belief that depression is associated with hyperactivity of the HPA-axis, resulting in higher cortisol levels. However, results are inconsistent. Our research aim was to determine whether there is an association between depression and cortisol levels in a large cohort, taking into account the use of psycho-active medication. Data are from 447 adults of the ongoing Netherlands Study of Depression and Anxiety. Participants were divided into 3 groups; 243 controls, 134 persons with major depressive disorder (MDD) without psycho-active medication and 100 with MDD with psycho-active medication. MDD was diagnosed using the CIDI interview and cortisol levels were measured in 7 saliva samples, covering a cortisol awakening response, basal evening level and a dexamethasone-suppression test. The 3 groups showed no significant differences in their cortisol awakening response. The mean value for the area under the curve with respect to the increase was 2.3 nmol/l*h for controls, 2.7 nmol/l*h for MDD without medication and 2.0 nmol/l*h for MDD with medication (p=0.77). In addition, basal evening levels and the ratio of morning cortisol before and after taking dexamethasone did not differ between groups. The findings did not change after adjustment for sociodemographics and health indicators. First results of this large cohort study indicate that depression is not associated with altered cortisol levels or difference in suppression after dexamethasone ingestion. Further analyses should explore the association between anxiety or trauma with cortisol values and whether there are certain subgroups of depressed patients with HPA-axis alterations.

Type
FC01. Free Communications: Mood Disorders
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.